Clinical Trials Directory

Trials / Completed

CompletedNCT01890382

Protein Intake and Resistance Training in Aging

Different Protein and Derivatives Supplementation Strategies Combined With Resistance Training in Pre-frail and Frail Elderly

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Resistance training combined with protein or amino acids supplementation has been shown to be promising for mitigating age-related disabilities and comorbidities. Randomized controlled trials supporting this possibility are still scarce. These series of clinical trials aim to investigate the chronic effects of different strategies of protein and derivatives supplementation in association with resistance training on selected health-related parameters in pre-frail and frail elderly.This is a 16-month, double-blind, randomized, placebo-controlled, parallel-group clinical trial involving a series of investigations. Participants will be divided into nine groups, allowing the assessement of the effects of (1) isolated leucine supplementation; (2) protein source (whey vs. soy); (3) combination of whey protein and creatine; and (4) sexual dimorphism to the response of protein intake plus resistance training (men vs. women). All participants will undergo a supervised, resistance training program.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTWhey protein30 g in total; twice a day (morning and evening)
DIETARY_SUPPLEMENTwhey plus creatinewhey protein combined with creatine (30 g and 6.0 g in total; twice a day, respectively)
DIETARY_SUPPLEMENTleucine supplementation7.5 g/d in total; three times per day
DIETARY_SUPPLEMENTsoy protein30 g in total; twice a day
DIETARY_SUPPLEMENTcreatine6.0 g in total; twice a day
DIETARY_SUPPLEMENTplacebo

Timeline

Start date
2015-10-01
Primary completion
2017-08-30
Completion
2017-08-30
First posted
2013-07-01
Last updated
2019-02-15

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01890382. Inclusion in this directory is not an endorsement.